These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 12969743)

  • 1. Glutamate metabotropic receptors as targets for drug therapy in epilepsy.
    Moldrich RX; Chapman AG; De Sarro G; Meldrum BS
    Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
    Chapman AG; Talebi A; Yip PK; Meldrum BS
    Eur J Pharmacol; 2001 Jul; 424(2):107-13. PubMed ID: 11476756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice.
    Moldrich RX; Talebi A; Beart PM; Chapman AG; Meldrum BS
    Neurosci Lett; 2001 Feb; 299(1-2):125-9. PubMed ID: 11166954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists.
    Johnson MP; Kelly G; Chamberlain M
    J Neuroendocrinol; 2001 Aug; 13(8):670-7. PubMed ID: 11489083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the actions of group I metabotropic glutamate receptor subtype selective ligands on excitatory amino acid release and sodium-dependent re-uptake in rat cerebrocortical minislices.
    Fazal A; Parker F; Palmer AM; Croucher MJ
    J Neurochem; 2003 Sep; 86(6):1346-58. PubMed ID: 12950444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).
    Moldrich RX; Jeffrey M; Talebi A; Beart PM; Chapman AG; Meldrum BS
    Neuropharmacology; 2001 Jul; 41(1):8-18. PubMed ID: 11445181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors.
    Schoepp DD; Salhoff CR; Wright RA; Johnson BG; Burnett JP; Mayne NG; Belagaje R; Wu S; Monn JA
    Neuropharmacology; 1996; 35(12):1661-72. PubMed ID: 9076745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Face-washing behavior induced by the group I metabotropic glutamate receptor agonist (S)-3,5-DHPG in mice is mediated by mGlu1 receptor.
    Hikichi H; Iwahori Y; Murai T; Maehara S; Satow A; Ohta H
    Eur J Pharmacol; 2008 May; 586(1-3):212-6. PubMed ID: 18378225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
    Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
    Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
    Mistry R; Golding N; Challiss RA
    Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands.
    Smolders I; Lindekens H; Clinckers R; Meurs A; O'Neill MJ; Lodge D; Ebinger G; Michotte Y
    J Neurochem; 2004 Mar; 88(5):1068-77. PubMed ID: 15009663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.
    Carroll FY; Stolle A; Beart PM; Voerste A; Brabet I; Mauler F; Joly C; Antonicek H; Bockaert J; Müller T; Pin JP; Prézeau L
    Mol Pharmacol; 2001 May; 59(5):965-73. PubMed ID: 11306677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
    Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sulphur-containing amino acids: potent agonists at presynaptic metabotropic glutamate autoreceptors in the rat central nervous system.
    Croucher MJ; Thomas LS; Ahmadi H; Lawrence V; Harris JR
    Br J Pharmacol; 2001 Jul; 133(6):815-24. PubMed ID: 11454654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
    Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    J Pharmacol Exp Ther; 2001 Aug; 298(2):453-60. PubMed ID: 11454905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).
    Chapman AG; Nanan K; Williams M; Meldrum BS
    Neuropharmacology; 2000 Jul; 39(9):1567-74. PubMed ID: 10854901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulators of metabotropic glutamate receptors microinfused into perirhinal cortex: anticonvulsant effects in rats challenged with soman.
    Myhrer T; Enger S; Aas P
    Eur J Pharmacol; 2010 Jun; 636(1-3):82-7. PubMed ID: 20347777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
    Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
    Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizures induced in immature rats by homocysteic acid and the associated brain damage are prevented by group II metabotropic glutamate receptor agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate.
    Folbergrová J; Druga R; Otáhal J; Haugvicová R; Mares P; Kubová H
    Exp Neurol; 2005 Apr; 192(2):420-36. PubMed ID: 15755559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.